Transforming/VBG
growth/NN
factor-beta/NN
suppresses/VBZ
human/JJ
B/NN
lymphocyte/NN
Ig/NN
production/NN
by/IN
inhibiting/VBG
synthesis/NN
and/CC
the/DT
switch/NN
from/IN
the/DT
membrane/NN
form/NN
to/TO
the/DT
secreted/JJ
form/NN
of/IN
Ig/NN
mRNA/NN
./.

Transforming/VBG
growth/NN
factor-beta/NN
(/(
TGF-beta/NN
)/)
inhibits/VBZ
B/NN
cell/NN
Ig/NN
secretion/NN
and/CC
reduces/VBZ
B/NN
cell/NN
membrane/NN
Ig/NN
expression/NN
./.
=====
The/DT
addition/NN
of/IN
TGF-beta/NN
to/TO
human/JJ
B/NN
lymphocyte/NN
cultures/NNS
stimulated/VBN
with/IN
Staphylococcus/FW
aureus/FW
Cowan/NN
strain/NN
I/NN
and/CC
IL-2/NN
completely/RB
inhibited/VBD
B/NN
cell/NN
Ig/NN
secretion/NN
(/(
greater/JJR
than/IN
90/CD
%/NN
)/)
and/CC
decreased/VBD
B/NN
cell/NN
surface/NN
IgM/NN
,/,
IgD/NN
,/,
kappa/NN
L/NN
chain/NN
,/,
and/CC
lambda/NN
L/NN
chain/NN
expression/NN
./.
=====
In/IN
contrast/NN
,/,
TGF-beta/NN
had/VBD
only/RB
minimal/JJ
effects/NNS
on/IN
two/CD
other/JJ
B/NN
cell/NN
membrane/NN
proteins/NNS
,/,
HLA-DR/NN
and/CC
CD20/NN
./.
=====
Internal/JJ
labeling/NN
with/IN
[35S]methionine/NN
and/CC
immunoprecipitation/NN
with/IN
anti-IgM/JJ
,/,
anti-kappa/JJ
,/,
and/CC
anti-lambda/JJ
antibodies/NNS
revealed/VBD
a/DT
striking/JJ
reduction/NN
in/IN
kappa/NN
L/NN
chain/NN
in/IN
the/DT
presence/NN
of/IN
TGF-beta/NN
./.
=====
A/DT
less/RBR
pronounced/JJ
reduction/NN
in/IN
lambda/NN
L/NN
chain/NN
and/CC
microH/NN
chain/NN
was/VBD
also/RB
noted/VBN
./.
=====
Northern/NN
blot/NN
analysis/NN
of/IN
RNA/NN
purified/VBN
from/IN
B/NN
cells/NNS
treated/VBN
with/IN
TGF-beta/NN
for/IN
varying/VBG
time/NN
intervals/NNS
revealed/VBD
a/DT
significant/JJ
decrease/NN
in/IN
steady/JJ
state/NN
kappa/NN
and/CC
lambda/NN
L/NN
chain/NN
mRNA/NN
levels/NNS
./.
=====
Furthermore/RB
,/,
a/DT
significant/JJ
decrease/NN
in/IN
the/DT
switch/NN
from/IN
the/DT
membrane/NN
forms/NNS
of/IN
mu/NN
and/CC
gamma/NN
to/TO
their/PRP$
respective/JJ
secreted/JJ
forms/NNS
was/VBD
noted/VBN
in/IN
the/DT
presence/NN
of/IN
TGF-beta/NN
./.
=====
Nuclear/JJ
run-on/JJ
experiments/NNS
demonstrated/VBD
decreased/VBN
transcription/NN
of/IN
kappa/NN
L/NN
chain/NN
./.
=====
The/DT
effects/NNS
of/IN
TGF-beta/NN
on/IN
two/CD
transcriptional/JJ
regulatory/JJ
factors/NNS
,/,
Oct-2/NN
and/CC
nuclear/JJ
factor/NN
(/(
NF/NN
)/)
kappa/NN
B/NN
,/,
known/VBN
to/TO
be/VB
important/JJ
in/IN
Ig/NN
gene/NN
transcription/NN
were/VBD
examined/VBN
./.
=====
Oct-2/NN
mRNA/NN
levels/NNS
and/CC
both/DT
Oct-2/NN
and/CC
NF-kappa/NN
B/NN
proteins/NNS
in/IN
nuclear/JJ
extracts/NNS
were/VBD
not/RB
altered/VBN
by/IN
treatment/NN
with/IN
TGF-beta/NN
./.
=====
In/IN
contrast/NN
,/,
levels/NNS
of/IN
the/DT
transcriptional/JJ
factor/NN
AP-1/NN
,/,
which/WDT
is/VBZ
not/RB
known/VBN
to/TO
be/VB
important/JJ
in/IN
B/NN
cell/NN
Ig/NN
production/NN
,/,
were/VBD
reduced/VBN
by/IN
TGF-beta/NN
./.
=====
These/DT
findings/NNS
demonstrate/VBP
that/IN
TGF-beta/NN
decreases/VBZ
B/NN
lymphocyte/NN
Ig/NN
secretion/NN
by/IN
inhibiting/VBG
the/DT
synthesis/NN
of/IN
Ig/NN
mRNA/NN
and/CC
inhibiting/VBG
the/DT
switch/NN
from/IN
the/DT
membrane/NN
form/NN
to/TO
the/DT
secreted/JJ
forms/NNS
of/IN
mu/NN
and/CC
gamma/NN
mRNA/NN
./.
=====
The/DT
mechanism/NN
by/IN
which/WDT
TGF-beta/NN
inhibits/VBZ
Ig/NN
chain/NN
synthesis/NN
is/VBZ
unclear/JJ
although/IN
it/PRP
does/VBZ
not/RB
involve/VB
inhibition/NN
of/IN
the/DT
binding/NN
of/IN
NF-kappa/NN
B/NN
or/CC
Oct-2/NN
to/TO
their/PRP$
respective/JJ
target/NN
sequences/NNS
./.